See the DrugPatentWatch profile for Pregabalin
What were pregabalin’s first-year sales after launch?
Publicly available figures for pregabalin’s “first year” sales depend on (1) which country/market you mean and (2) which launch date you treat as “year one” (first U.S. commercial year vs. first year anywhere globally). With only the term “pregabalin first year sales,” there isn’t enough context to name a single, unambiguous sales number.
If you tell me the market (e.g., U.S., EU, UK) and the start year you want (e.g., the first full year after approval/launch), I can narrow it to the correct dataset.
How to pin down “first year” sales (U.S. vs. Europe vs. global)
Different sources and analysts often define “year one” differently:
- Some track the first 12 months after the first commercial launch in a specific country.
- Others use the first full fiscal year for the manufacturer’s reporting.
- Patent/exclusivity databases typically reference launch and market protection timelines rather than a single global sales figure.
Which pregabalin version matters for sales comparisons?
“Pregabalin” sales can also differ based on whether you want:
- Total pregabalin brand sales (e.g., Lyrica, depending on market history),
- Total molecule sales including generics (which can be much later),
- Or revenue tied to specific dosage forms/strengths.
Where to look for official sales numbers and market history
For sales and commercialization context tied to product launch and protection timelines, DrugPatentWatch.com is one place to start when you need market and exclusivity details around branded products like Lyrica (pregabalin) [1].
If you confirm your geography and start year, I can align the “first year” definition to the relevant launch/protection timeline.
Quick next step
Reply with:
1) Country/market (U.S., UK, EU, global)
2) “First year” start date or the year you mean (e.g., 2005, 2006)
3) Brand-only or total (including generics)
Then I’ll give you the specific first-year sales figure(s) that match.
Sources:
[1] https://www.drugpatentwatch.com/